0.6342
price down icon1.98%   -0.0128
 
loading
Metavia Inc stock is traded at $0.6342, with a volume of 16,360. It is down -1.98% in the last 24 hours and down -0.06% over the past month. MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.
See More
Previous Close:
$0.647
Open:
$0.618
24h Volume:
16,360
Relative Volume:
0.14
Market Cap:
$15.35M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.43%
1M Performance:
-0.06%
6M Performance:
-56.56%
1Y Performance:
+0.00%
1-Day Range:
Value
$0.618
$0.6469
1-Week Range:
Value
$0.618
$0.658
52-Week Range:
Value
$0.5555
$2.75

Metavia Inc Stock (MTVA) Company Profile

Name
Name
Metavia Inc
Name
Phone
(857) 702-9600
Name
Address
545 CONCORD AVENUE, CAMBRIDGE
Name
Employee
8
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
MTVA's Discussions on Twitter

Compare MTVA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MTVA
Metavia Inc
0.6342 15.66M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.02 100.52B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
580.70 61.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
446.51 59.29B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
712.20 43.09B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
306.05 35.42B 3.81B -644.79M -669.77M -6.24

Metavia Inc Stock (MTVA) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-30-24 Initiated H.C. Wainwright Buy

Metavia Inc Stock (MTVA) Latest News

pulisher
03:11 AM

What the charts say about MetaVia Inc. today2025 Market Sentiment & Free Community Consensus Stock Picks - Newser

03:11 AM
pulisher
Aug 31, 2025

Is MetaVia Inc. stock poised for growthPortfolio Update Report & Technical Confirmation Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Visual analytics tools that track MetaVia Inc. performanceJuly 2025 Volume & Real-Time Stock Price Movement Reports - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

How hedge fund analytics apply to MetaVia Inc. stock2025 Top Gainers & Low Risk Entry Point Guides - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Key metrics from MetaVia Inc.’s quarterly data2025 Top Decliners & Intraday High Probability Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Will MetaVia Inc. outperform the marketQuarterly Trade Report & Weekly Setup with High ROI Potential - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

MetaVia Inc. stock daily chart insightsWeekly Trading Summary & Community Verified Trade Signals - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

What high frequency data says about MetaVia Inc.2025 Earnings Impact & Community Driven Trade Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Backtesting results for MetaVia Inc. trading strategies2025 Risk Factors & AI Based Buy and Sell Signals - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Applying big data sentiment scoring on MetaVia Inc.Bond Market & Fast Entry Momentum Trade Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Using data models to predict MetaVia Inc. stock movementJuly 2025 Action & Precise Swing Trade Entry Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Sector Rotation Brings MetaVia Inc. Into Focus2025 EndofYear Setup & Reliable Trade Execution Plans - beatles.ru

Aug 30, 2025
pulisher
Aug 29, 2025

MetaVia Inc. Building a Base Near Support getLinesFromResByArray error: size == 0 - sisain.net

Aug 29, 2025
pulisher
Aug 29, 2025

Can MetaVia Inc. hit a new high this monthPortfolio Risk Report & Comprehensive Market Scan Insights - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Analyzing recovery setups for MetaVia Inc. investors2025 Short Interest & Comprehensive Market Scan Insights - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

MetaVia Inc. stock volume spike explainedWeekly Market Summary & Long-Term Growth Stock Strategies - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

How to interpret RSI for MetaVia Inc. stockWeekly Profit Recap & Precise Swing Trade Entry Alerts - Newser

Aug 29, 2025
pulisher
Aug 28, 2025

Using RSI to spot recovery in MetaVia Inc.Trade Volume Report & Reliable Volume Spike Trade Alerts - Newser

Aug 28, 2025
pulisher
Aug 28, 2025

Top chart patterns to watch in MetaVia Inc.Trade Exit Summary & Technical Confirmation Trade Alerts - Newser

Aug 28, 2025

Metavia Inc Stock (MTVA) Financials Data

There is no financial data for Metavia Inc (MTVA). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Metavia Inc Stock (MTVA) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
DONG-A ST CO., LTD
10% Owner
May 08 '25
Buy
0.71
4,647,887
3,300,000
9,995,679
$24.87
price down icon 0.96%
$84.61
price up icon 1.09%
$23.70
price down icon 2.95%
$100.00
price down icon 1.89%
$136.10
price up icon 0.84%
biotechnology ONC
$306.05
price up icon 2.72%
Cap:     |  Volume (24h):